Case reports on mistletoe therapy for neuroblastoma

Case 1: Supportive mistletoe in a patient with metastasised neuroblastoma

 

Last update: May 13th, 2020/AB

Case 1

Supportive mistletoe in a patient with metastasised neuroblastoma

Kaestner J et al. 2019 [267]

An 18-year-old female patient with metastatic low-differentiated neuroblastoma with distinctive pain symptoms responded inadequately and with poor tolerability to oncological treatment.

After discontinuation of chemotherapy while continuing therapy with bisphosphonates, she was additionally treated with subcutaneously administered mistletoe extracts. The tumour foci were demonstrably constant in size 15 months after the start of the additional mistletoe therapy (MRI). 20 months after the start of mistletoe therapy, MRI showed renewed growth of the bone metastases – but the patient herself complained neither of pain nor of a deterioration in her general condition.

 

Last update: May 13th, 2020/AB

Go to Heaven